Studios must verify batch-level REACH compliance, not merely collect reassuring certificates
Key Takeaways:
» No concrete new body-art restriction was identified in the available official-source results from the last 14 days.
» The most actionable current requirement remains EU REACH Annex XVII’s tattoo-ink restriction, effective from 4 January 2022.
» The restriction covers more than 4,000 hazardous substances, including certain CMR substances, sensitisers, irritants, metals, PAHs and methanol.
» Tattoo-ink labels must identify the intended tattoo or permanent-makeup use, list ingredients and carry relevant safety statements.
» Studios should obtain current batch documentation—not generic claims of “EU compliant”—before using or importing ink.
1. The significant development is still operational enforcement
The available official results do not show a new body-art regulatory measure published within the last 14 days. The most significant actionable framework remains the European Union’s REACH Annex XVII restriction for tattoo inks and permanent make-up, which has applied across the EU/EEA since 4 January 2022.ECHA’s tattoo-ink regulatory summary confirms both the effective date and the scope of the restriction.
That is not a reason to relax. It is a reason to stop confusing an old legal deadline with a finished compliance task. REACH limits more than 4,000 hazardous chemicals in tattoo inks and permanent make-up, using maximum concentration limits for individual substances or substance groups. The regulated categories include certain carcinogenic, mutagenic or reprotoxic substances, skin sensitisers, skin irritants, metals, polycyclic aromatic hydrocarbons and methanol.ECHA’s explanation of the restricted substance groups describes the breadth of the measure.
The practical issue is the supply chain. A studio may have a bottle labelled for the European market while holding no evidence that the actual batch was tested against the applicable limits. A distributor’s catalogue statement is not a laboratory result, and a certificate issued for one formulation or manufacturing site does not automatically validate every later batch. The EU tattoo-ink labelling and compliance obligations are therefore best treated as a working control system, not a box to tick once.
2. What the EU restriction requires—and what it does not
REACH does not create one universal “safe tattoo ink” certification. It restricts specified substances and concentration thresholds and imposes information requirements on mixtures intended for tattooing or permanent make-up. ECHA states that labels must mention the intended use, provide an ingredient list and include relevant safety statements.ECHA’s official tattoo-ink requirements provide the controlling summary.
| Feature | EU/EEA REACH position | United States position |
|---|---|---|
| Primary legal framework | REACH Annex XVII restriction applies from 4 January 2022 | No equivalent single federal REACH-style tattoo-ink restriction identified in the available results |
| Scope | More than 4,000 hazardous chemicals, including CMRs, sensitisers, irritants, metals, PAHs and methanol | Federal oversight exists, but state and local requirements remain significant |
| Concentration control | Substance-specific or group-specific maximum concentration limits | No single federal threshold system equivalent to Annex XVII identified here |
| Label information | Intended tattoo/PMU use, ingredients and relevant safety statements | Requirements depend on applicable federal, state and local rules |
| Studio responsibility | Non-compliant mixtures must not be used in tattooing or PMU | Studios must verify applicable jurisdictional requirements and supplier evidence |
The comparison matters for manufacturers and importers. “FDA compliant” does not mean “REACH compliant,” just as an EU label does not establish compliance with every US state rule. A product crossing the Atlantic needs a jurisdiction-specific compliance file, not one impressive-looking PDF doing administrative overtime.
There is also a narrow historical transition worth remembering: Pigment Blue 15:3 and Pigment Green 7 received a 24-month transition period and became subject to the restriction on 4 January 2023.ECHA’s transition-date notice confirms that those pigments are no longer protected by the original transition window.
3. Technical control: thresholds, labels and supplier evidence
The central technical requirement is not a single ppm number that applies to every pigment. Annex XVII uses substance-specific and group-specific limits. That means a studio cannot responsibly approve an ink by asking only whether it contains “heavy metals” or whether the manufacturer says it is “non-toxic.” The relevant question is whether the formulation complies with every applicable restriction for the substances, impurities and classifications present.
For each product, request:
- A current Safety Data Sheet, prepared for the destination market and reflecting the current formulation.
- A complete ingredient or colour-index disclosure sufficient to identify restricted substances.
- A batch or lot number linked to the compliance documentation.
- A supplier declaration specifically stating compliance with REACH Annex XVII, Entry 75, where the product is sold for EU/EEA tattooing or permanent make-up.
- Test reports identifying the laboratory, test method, detection limits, sample identity and test date.
- Evidence covering relevant impurities, particularly restricted aromatic amines, PAHs, metals and methanol where applicable.
- Confirmation that the label includes intended use, ingredients and required safety statements.
A generic certificate of analysis is not enough if it reports only microbiology, sterility or heavy metals while saying nothing about the restricted substance groups relevant to the colourant. Nor is “vegan,” “organic,” “sterile” or “professional grade” a regulatory conclusion. Those descriptors may describe useful product characteristics, but none substitutes for Annex XVII evidence.
Studios should also control stock rotation. Photograph the label when a shipment arrives, record the lot number, retain the invoice and quarantine any bottle whose label, SDS or documentation has changed unexpectedly. If a supplier cannot identify which formulation a certificate covers, the missing information is itself a compliance finding.
For manufacturers, the evidence package should be formulation-controlled. When a pigment, dispersant, preservative or manufacturing site changes, the REACH assessment must be revisited. “Same product name” is not the same as “same regulated mixture.” The burden becomes especially serious for private-label products, where the studio may be several steps removed from the actual formulator.
4. Patrick's Note: The Certificate Is Not the Product
A clean certificate sitting in a supplier’s inbox does not make a non-compliant bottle lawful. The person opening the bottle needs traceable evidence tied to the lot in hand, while the industry keeps producing certificates that appear designed mainly to reassure purchasing departments.
The useful question is brutally simple: what exactly was tested, when, by whom, and against which legal limits? I have put the practical tattoo-ink compliance file for studios and suppliers together around that question because paperwork should protect the practitioner and client—not merely give an importer something to forward when challenged.
5. FAQ: Technical Q&A
Q: Can a studio keep using existing ink if the bottle says “EU compliant”?
No. The wording is useful only when supported by traceable documentation. Record the lot, obtain a current SDS and request a supplier declaration specifically tied to REACH Annex XVII Entry 75 and the product formulation.
Q: Does a certificate showing heavy metals prove REACH compliance?
No. REACH covers substantially more than metals. Depending on the formulation, evidence may also need to address CMR substances, sensitisers, irritants, PAHs, methanol, prohibited aromatic amines and other restricted substances.
Q: What should a studio do when the supplier will not disclose the full formulation?
Do not treat non-disclosure as proof of non-compliance, but do not treat it as proof of compliance either. Ask for a legally adequate ingredient disclosure or an independent test report that identifies the tested mixture, lot and applicable limits; until then, quarantine the product for EU/EEA use.
Conclusion: Build the File Before the Inspection
The latest available official-source results do not establish a new regulatory change in the past 14 days. The enforceable reality remains the EU’s REACH tattoo-ink restriction: more than 4,000 hazardous chemicals are controlled, specific concentration limits apply, and compliant labelling is mandatory.ECHA’s current official overview remains the starting point.
Studios should audit every active ink line now: photograph labels, match lots to SDSs, request Entry 75 declarations and retain test reports with methods and detection limits. The studio action plan for tattoo-ink regulatory compliance is simple: if the evidence cannot identify the tested product and the legal limits applied, the file is incomplete.
